NeuroPace (NPCE) Stock Forecast & Price Target

$11.93 +0.36 (+3.11%)

As of 01/6/2025 04:00 PM Eastern

NeuroPace - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 6 Analyst Ratings

Sell
0

Hold
1

Buy
5

Based on 6 Wall Street analysts who have issued ratings for NeuroPace in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 1 has given a hold rating, and 5 have given a buy rating for NPCE.

Consensus Price Target

$15.00
25.73% Upside

According to the 6 analysts' twelve-month price targets for NeuroPace, the average price target is $15.00. The highest price target for NPCE is $22.00, while the lowest price target for NPCE is $8.00. The average price target represents a forecasted upside of 25.73% from the current price of $11.93.

Get the Latest News and Ratings for NPCE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for NeuroPace and its competitors.

NPCE Analyst Ratings Over Time

Type	Current Forecast 1/8/24 to 1/7/25	1 Month Ago 12/9/23 to 12/8/24	3 Months Ago 10/10/23 to 10/9/24	1 Year Ago 1/8/23 to 1/8/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	6 Buy rating(s)	3 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$15.00	$14.60	$14.00	$10.00
Forecasted Upside	25.73% Upside	29.43% Upside	129.13% Upside	-19.03% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

[EXPOSED] Little-known Bitcoin “Loophole” (Ad)

I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free…

If you want in, Just Click Here

NPCE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NPCE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

NeuroPace Stock vs. The Competition

Type	NeuroPace	Medical Companies	S&P 500
Consensus Rating Score	2.83	2.82	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	25.73% Upside	23,959.37% Upside	14.69% Upside
News Sentiment Rating	Neutral News See Recent NPCE News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	JPMorgan Chase & Co. 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$9.00 ➝ $14.00	+12.99%
11/13/2024	Wells Fargo & Company 3 of 5 stars		Lower Target	Overweight ➝ Overweight	$15.00 ➝ $13.00	+58.73%
8/14/2024	Cantor Fitzgerald 4 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$18.00 ➝ $18.00	+137.78%
7/15/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$9.50 ➝ $8.00	+1.14%
1/30/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kratky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
1/30/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$22.00	+49.15%
12/27/2023	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$12.00	+21.95%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:16 AM ET.

NPCE Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for NeuroPace is $15.00, with a high forecast of $22.00 and a low forecast of $8.00.
: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NeuroPace in the last twelve months. There is currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NPCE shares.
: According to analysts, NeuroPace's stock has a predicted upside of 25.73% based on their 12-month stock forecasts.
: NeuroPace has been rated by research analysts at JPMorgan Chase & Co., and Wells Fargo & Company in the past 90 days.
: Analysts like NeuroPace more than other "medical" companies. The consensus rating score for NeuroPace is 2.83 while the average consensus rating score for "medical" companies is 2.82. Learn more on how NPCE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Grab these five dividend cheat sheets (Ad)

Would you like a simple set of guidelines for building a rock solid dividend portfolio? Including the two specific tickers I just put $50k into? Well, it’s all included in these FIVE Dividend Cheat Sheets

>> You can grab your FREE, laminated copies right here <<

This page (NASDAQ:NPCE) was last updated on 1/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NeuroPace (NPCE) Stock Forecast & Price Target